David Kugler is Vice President of Immunology at Cartography Biosciences; he partners with the Discovery, Platform and Development teams to advance novel targets to lead candidates. Most recently before joining Cartography he was a Scientific Director at Juno Therapeutics/Bristol-Myers Squibb focused on building autologous and allogeneic cell therapy programs and platforms. David completed his PhD studying immune regulation in the context of infectious disease at Johns Hopkins University in partnership with the National Institutes for Allergy and Infectious Disease. Outside of work, David spends time traveling with his family and exploring the outdoors.
Recent Posts
- Cartography Biosciences Expands Leadership Team with Appointment of Dan Rock, Ph.D., as Chief Scientific Officer to Advance Novel Oncology Programs into Clinic
- Cartography Biosciences and Nested Therapeutics: Diamonds in the rough
- Cartography Biosciences Expands Scientific Advisory Board with Leading Antibody and Bi-specific Experts
- Cartography Biosciences Co-Founder and Chief Executive Officer Kevin Parker, Ph.D., Earns Spot on Endpoints News’ 20 Under 40 List
- Cartography Biosciences Appoints Industry Veteran as Chief Administrative and Legal Officer
Recent Comments
No comments to show.